22 November 2017 | News
Serial Entrepreneur Dr. Srinubabu buys Canada’s Health Informatics Company PULSUS; to open New Centers at Chennai and Gurgaon
Pulsus focus will be to lead Pharmacovigilance works including collection, archival and monitoring of Individual Case Study Reports, studies in the global market. To increase headcount from 500 to 2000 by 2018
Hyderabad based Serial entrepreneur Dr. Srinubabu has acquired Canada based scientific medical informatics Pulsus Group Inc. The company will foray into big scientific, medical informatics market worldwide for an undisclosed amount.
Dr. Srinubabu also announced PULSUS will expand in India with 2 new centers; Chennai and Gurgaon in next few months and these 2 centers will be an addition to Hyderabad center.
Established in the year 1984, Pulsus initially focused on American region and presently it is expanding to healthcare informatics platform to the medical and pharma professionals throughout Europe, America, Asia, Australia and all other continents.
Since its inception, Pulsus received the endorsements of the medical associations and industries of the international reputation.
"PULSUS is committed to building the domestic scientific and medical Informatics market supported by a team of 500 people with a target to grow the team to 2000 by early next year. This is a 100% acquisition through a combination of cash and equity.” Dr. Srinubabu stated who will spearhead the venture as CEO.
Dr. Srinu commented on release that “In recent years, cities like Chennai and Gurgaon has become increasingly important as a center for science and research, as can be seen in the growing number of universities and companies with R & D departments”.
“PULSUS is young in India; our aim is to become the authentic healthcare informatics source for university libraries, research institutes, students and academics, as well as for corporate R & D departments”. Dr. Srinu said.
Stating about PULSUS activities Dr. Srinu said “In every city we will work with partners in the region to develop publications of worldwide interest and enhance reputation to our high scientific standards.
These offices will be serving all of its clients and potential clients for all related products and services. Our target is to open our center in New Delhi early 2018.